0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiology Point-of-Care (POC) Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-2I4544
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Cardiology Point of Care POC Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cardiology Point-of-Care (POC) Diagnostics Market Research Report 2025

Code: QYRE-Auto-2I4544
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cardiology Point-of-Care (POC) Diagnostics Market Size

The global market for Cardiology Point-of-Care (POC) Diagnostics was valued at US$ 156 million in the year 2024 and is projected to reach a revised size of US$ 269 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Cardiology Point-of-Care (POC) Diagnostics Market

Cardiology Point-of-Care (POC) Diagnostics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cardiology Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiology Point-of-Care (POC) Diagnostics.
The Cardiology Point-of-Care (POC) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiology Point-of-Care (POC) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiology Point-of-Care (POC) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cardiology Point-of-Care (POC) Diagnostics Market Report

Report Metric Details
Report Name Cardiology Point-of-Care (POC) Diagnostics Market
Accounted market size in year US$ 156 million
Forecasted market size in 2031 US$ 269 million
CAGR 8.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Cardiometabolic Monitoring
  • Cardiometabolic Diagnostics
Segment by Application
  • Professional Diagnostic Centers
  • Hospitals/Critical Care Centers
  • Research Laboratories
  • Home Care
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Siemens, Abbott, Roche, Opko, GE Healthcare, Samsung Health, BioMerieux, Terumo, Accriva, Akers, Radiometer, Response Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cardiology Point-of-Care (POC) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cardiology Point-of-Care (POC) Diagnostics Market growing?

Ans: The Cardiology Point-of-Care (POC) Diagnostics Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Cardiology Point-of-Care (POC) Diagnostics Market size in 2031?

Ans: The Cardiology Point-of-Care (POC) Diagnostics Market size in 2031 will be US$ 269 million.

Who are the main players in the Cardiology Point-of-Care (POC) Diagnostics Market report?

Ans: The main players in the Cardiology Point-of-Care (POC) Diagnostics Market are Siemens, Abbott, Roche, Opko, GE Healthcare, Samsung Health, BioMerieux, Terumo, Accriva, Akers, Radiometer, Response Biomedical

What are the Application segmentation covered in the Cardiology Point-of-Care (POC) Diagnostics Market report?

Ans: The Applications covered in the Cardiology Point-of-Care (POC) Diagnostics Market report are Professional Diagnostic Centers, Hospitals/Critical Care Centers, Research Laboratories, Home Care

What are the Type segmentation covered in the Cardiology Point-of-Care (POC) Diagnostics Market report?

Ans: The Types covered in the Cardiology Point-of-Care (POC) Diagnostics Market report are Cardiometabolic Monitoring, Cardiometabolic Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cardiometabolic Monitoring
1.2.3 Cardiometabolic Diagnostics
1.3 Market by Application
1.3.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Professional Diagnostic Centers
1.3.3 Hospitals/Critical Care Centers
1.3.4 Research Laboratories
1.3.5 Home Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Perspective (2020-2031)
2.2 Global Cardiology Point-of-Care (POC) Diagnostics Growth Trends by Region
2.2.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Cardiology Point-of-Care (POC) Diagnostics Market Dynamics
2.3.1 Cardiology Point-of-Care (POC) Diagnostics Industry Trends
2.3.2 Cardiology Point-of-Care (POC) Diagnostics Market Drivers
2.3.3 Cardiology Point-of-Care (POC) Diagnostics Market Challenges
2.3.4 Cardiology Point-of-Care (POC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Revenue
3.1.1 Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cardiology Point-of-Care (POC) Diagnostics Revenue
3.4 Global Cardiology Point-of-Care (POC) Diagnostics Market Concentration Ratio
3.4.1 Global Cardiology Point-of-Care (POC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2024
3.5 Global Key Players of Cardiology Point-of-Care (POC) Diagnostics Head office and Area Served
3.6 Global Key Players of Cardiology Point-of-Care (POC) Diagnostics, Product and Application
3.7 Global Key Players of Cardiology Point-of-Care (POC) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiology Point-of-Care (POC) Diagnostics Breakdown Data by Type
4.1 Global Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2026-2031)
5 Cardiology Point-of-Care (POC) Diagnostics Breakdown Data by Application
5.1 Global Cardiology Point-of-Care (POC) Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cardiology Point-of-Care (POC) Diagnostics Market Size (2020-2031)
6.2 North America Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
6.4 North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size (2020-2031)
7.2 Europe Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
7.4 Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size (2020-2031)
9.2 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Cardiology Point-of-Care (POC) Diagnostics Introduction
11.1.4 Siemens Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.1.5 Siemens Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Introduction
11.2.4 Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Cardiology Point-of-Care (POC) Diagnostics Introduction
11.3.4 Roche Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Opko
11.4.1 Opko Company Details
11.4.2 Opko Business Overview
11.4.3 Opko Cardiology Point-of-Care (POC) Diagnostics Introduction
11.4.4 Opko Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.4.5 Opko Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Introduction
11.5.4 GE Healthcare Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 Samsung Health
11.6.1 Samsung Health Company Details
11.6.2 Samsung Health Business Overview
11.6.3 Samsung Health Cardiology Point-of-Care (POC) Diagnostics Introduction
11.6.4 Samsung Health Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.6.5 Samsung Health Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Cardiology Point-of-Care (POC) Diagnostics Introduction
11.7.4 BioMerieux Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.7.5 BioMerieux Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Cardiology Point-of-Care (POC) Diagnostics Introduction
11.8.4 Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.8.5 Abbott Recent Development
11.9 Terumo
11.9.1 Terumo Company Details
11.9.2 Terumo Business Overview
11.9.3 Terumo Cardiology Point-of-Care (POC) Diagnostics Introduction
11.9.4 Terumo Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.9.5 Terumo Recent Development
11.10 Accriva
11.10.1 Accriva Company Details
11.10.2 Accriva Business Overview
11.10.3 Accriva Cardiology Point-of-Care (POC) Diagnostics Introduction
11.10.4 Accriva Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.10.5 Accriva Recent Development
11.11 Akers
11.11.1 Akers Company Details
11.11.2 Akers Business Overview
11.11.3 Akers Cardiology Point-of-Care (POC) Diagnostics Introduction
11.11.4 Akers Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.11.5 Akers Recent Development
11.12 Radiometer
11.12.1 Radiometer Company Details
11.12.2 Radiometer Business Overview
11.12.3 Radiometer Cardiology Point-of-Care (POC) Diagnostics Introduction
11.12.4 Radiometer Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.12.5 Radiometer Recent Development
11.13 Response Biomedical
11.13.1 Response Biomedical Company Details
11.13.2 Response Biomedical Business Overview
11.13.3 Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Introduction
11.13.4 Response Biomedical Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
11.13.5 Response Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cardiometabolic Monitoring
 Table 3. Key Players of Cardiometabolic Diagnostics
 Table 4. Global Cardiology Point-of-Care (POC) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Region (2020-2025)
 Table 8. Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Region (2026-2031)
 Table 10. Cardiology Point-of-Care (POC) Diagnostics Market Trends
 Table 11. Cardiology Point-of-Care (POC) Diagnostics Market Drivers
 Table 12. Cardiology Point-of-Care (POC) Diagnostics Market Challenges
 Table 13. Cardiology Point-of-Care (POC) Diagnostics Market Restraints
 Table 14. Global Cardiology Point-of-Care (POC) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Players (2020-2025)
 Table 16. Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Point-of-Care (POC) Diagnostics as of 2024)
 Table 17. Ranking of Global Top Cardiology Point-of-Care (POC) Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cardiology Point-of-Care (POC) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cardiology Point-of-Care (POC) Diagnostics, Headquarters and Area Served
 Table 20. Global Key Players of Cardiology Point-of-Care (POC) Diagnostics, Product and Application
 Table 21. Global Key Players of Cardiology Point-of-Care (POC) Diagnostics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Type (2020-2025)
 Table 25. Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Type (2026-2031)
 Table 27. Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Application (2020-2025)
 Table 29. Global Cardiology Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cardiology Point-of-Care (POC) Diagnostics Revenue Market Share by Application (2026-2031)
 Table 31. North America Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Siemens Company Details
 Table 47. Siemens Business Overview
 Table 48. Siemens Cardiology Point-of-Care (POC) Diagnostics Product
 Table 49. Siemens Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 50. Siemens Recent Development
 Table 51. Abbott Company Details
 Table 52. Abbott Business Overview
 Table 53. Abbott Cardiology Point-of-Care (POC) Diagnostics Product
 Table 54. Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 55. Abbott Recent Development
 Table 56. Roche Company Details
 Table 57. Roche Business Overview
 Table 58. Roche Cardiology Point-of-Care (POC) Diagnostics Product
 Table 59. Roche Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 60. Roche Recent Development
 Table 61. Opko Company Details
 Table 62. Opko Business Overview
 Table 63. Opko Cardiology Point-of-Care (POC) Diagnostics Product
 Table 64. Opko Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 65. Opko Recent Development
 Table 66. GE Healthcare Company Details
 Table 67. GE Healthcare Business Overview
 Table 68. GE Healthcare Cardiology Point-of-Care (POC) Diagnostics Product
 Table 69. GE Healthcare Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 70. GE Healthcare Recent Development
 Table 71. Samsung Health Company Details
 Table 72. Samsung Health Business Overview
 Table 73. Samsung Health Cardiology Point-of-Care (POC) Diagnostics Product
 Table 74. Samsung Health Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 75. Samsung Health Recent Development
 Table 76. BioMerieux Company Details
 Table 77. BioMerieux Business Overview
 Table 78. BioMerieux Cardiology Point-of-Care (POC) Diagnostics Product
 Table 79. BioMerieux Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 80. BioMerieux Recent Development
 Table 81. Abbott Company Details
 Table 82. Abbott Business Overview
 Table 83. Abbott Cardiology Point-of-Care (POC) Diagnostics Product
 Table 84. Abbott Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 85. Abbott Recent Development
 Table 86. Terumo Company Details
 Table 87. Terumo Business Overview
 Table 88. Terumo Cardiology Point-of-Care (POC) Diagnostics Product
 Table 89. Terumo Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 90. Terumo Recent Development
 Table 91. Accriva Company Details
 Table 92. Accriva Business Overview
 Table 93. Accriva Cardiology Point-of-Care (POC) Diagnostics Product
 Table 94. Accriva Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 95. Accriva Recent Development
 Table 96. Akers Company Details
 Table 97. Akers Business Overview
 Table 98. Akers Cardiology Point-of-Care (POC) Diagnostics Product
 Table 99. Akers Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 100. Akers Recent Development
 Table 101. Radiometer Company Details
 Table 102. Radiometer Business Overview
 Table 103. Radiometer Cardiology Point-of-Care (POC) Diagnostics Product
 Table 104. Radiometer Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 105. Radiometer Recent Development
 Table 106. Response Biomedical Company Details
 Table 107. Response Biomedical Business Overview
 Table 108. Response Biomedical Cardiology Point-of-Care (POC) Diagnostics Product
 Table 109. Response Biomedical Revenue in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025) & (US$ Million)
 Table 110. Response Biomedical Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Cardiology Point-of-Care (POC) Diagnostics Picture
 Figure 2. Global Cardiology Point-of-Care (POC) Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Cardiometabolic Monitoring Features
 Figure 5. Cardiometabolic Diagnostics Features
 Figure 6. Global Cardiology Point-of-Care (POC) Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Application: 2024 VS 2031
 Figure 8. Professional Diagnostic Centers Case Studies
 Figure 9. Hospitals/Critical Care Centers Case Studies
 Figure 10. Research Laboratories Case Studies
 Figure 11. Home Care Case Studies
 Figure 12. Cardiology Point-of-Care (POC) Diagnostics Report Years Considered
 Figure 13. Global Cardiology Point-of-Care (POC) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cardiology Point-of-Care (POC) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Region: 2024 VS 2031
 Figure 16. Global Cardiology Point-of-Care (POC) Diagnostics Market Share by Players in 2024
 Figure 17. Global Top Cardiology Point-of-Care (POC) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Point-of-Care (POC) Diagnostics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cardiology Point-of-Care (POC) Diagnostics Revenue in 2024
 Figure 19. North America Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cardiology Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 21. United States Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cardiology Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 25. Germany Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cardiology Point-of-Care (POC) Diagnostics Market Share by Region (2020-2031)
 Figure 33. China Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cardiology Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 41. Mexico Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cardiology Point-of-Care (POC) Diagnostics Market Share by Country (2020-2031)
 Figure 45. Turkey Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cardiology Point-of-Care (POC) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Siemens Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 49. Abbott Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 50. Roche Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 51. Opko Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 52. GE Healthcare Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 53. Samsung Health Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 54. BioMerieux Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 55. Abbott Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 56. Terumo Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 57. Accriva Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 58. Akers Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 59. Radiometer Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 60. Response Biomedical Revenue Growth Rate in Cardiology Point-of-Care (POC) Diagnostics Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS